CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Zoetis (ZTC) is the largest animal health company. Zoetis produces vaccines and medicines marketed in over 100 countries, providing support to 8 animal species (horses, dogs, cats, fish, poultry, swine, cattle and sheep). Their portfolio includes Palladia, Draxxin, A180, etc. In all, the brand offers 5 categories of marketed products. The company employs approximately 9,000 people including over 1,000 specialists engaged in research and development. Zoetis shares are traded on the New York Stock Exchange (NYSE). The company is the S&P 500 index constituent. To receive updates on the Zoetis share price, follow Capital.com.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.